Momenta Pharmaceuticals, Inc. (NASDAQ : MNTA) today reported positive top-line data showing safety, tolerability and proof of mechanism for M281 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE